CoChat

Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy

Open access
van Waart, Hanna, van Dongen, Johanna M., van Harten, Wim H., Stuiver, Martijn M., Huijsmans, Rosalie, Hellendoorn-van Vreeswijk, Jeannette A. J. H., Sonke, Gabe S., Aaronson, Neil K. · 2018 · The European Journal of Health Economics

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Introduction A home-based, low-intensity physical activity program (Onco-Move) and a supervised, moderate-to-high intensity, combined resistance and aerobic exercise program (OnTrack) have proven to be effective in maintaining physical fitness and reducing fatigue among breast cancer patients undergoing adjuvant chemotherapy. This study evaluated the cost-utility and cost-effectiveness of Onco-Move and OnTrack.Methods A total of 230 patients were randomized to Onco-Move, OnTrack, or usual care (UC). Health outcomes included quality-adjusted life years (QALYs), general and physical fatigue, and physical fitness measured at baseline, end of chemotherapy, and 6-month follow-up. Societal costs included professional and informal health care, work absenteeism, and unpaid productivity costs. Cost data were based on 3-monthly questionnaires, supplemented by medication data obtained from pharmacies.Results Onco-Move is not likely to be cost-effective due to the relatively high willingness-to-pay necessary to reach reasonable probabilities of cost-effectiveness (QALY, general and physical fatigue). Incremental cost-effectiveness ratios for OnTrack compared to UC were €26,916/QALY, €788/1-point decrease in general fatigue and €1402/1-point decrease in physical fatigue. The probability of OnTrack being cost-effective ranged from 31% at a willingness-to-pay (WTP) of €0-79% at a WTP of €80,000/QALY, 97% at a WTP of €15,000/1-point decrease in general fatigue, and 86% at a WTP of €24,000/1-point decrease in physical fatigue. Both interventions had a low probability of being cost-effective for physical fitness. The probability of cost-effectiveness for both interventions was greater among compliant participants.Conclusions Onco-Move is not likely to be cost-effective. Depending on the decision-makers' willingness-to-pay, OnTrack could be considered cost-effective in comparison with UC. Trial registration Clinical trial registration number of the Netherlands Trial Register-NTR2159.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10198-017-0936-0

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 29 references

Research works printed but not linked: 1

  1. Mock, V., Cameron, L., Tompkins, C., Lin, E., Stewart, K.: Every Step Counts: A Walking Exercise Program for Persons With Cancer. The John Hopkins University, Baltimore (2008)

Cited by

See all 56

Metadata

Authors
van Waart, H., van Dongen, J. M., van Harten, W. H., Stuiver, M. M., Huijsmans, R., Hellendoorn-van Vreeswijk, J. A. J. H., Sonke, G. S., & Aaronson, N. K.
Affiliations
  • The Netherlands Cancer Institute (NL)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Corresponding author
Aaronson, Neil K.
Venue
The European Journal of Health Economics
Published
2017-10-30
Volume
19
Issue
6
Pages
893-904
ISSN
  • 1439-3972 (ISSN-L)
  • 1618-7598
  • 1618-7601
OpenAlex
W2765762403
Cited by
56
References
29
Citations by year
2026: 3 · 2025: 5 · 2024: 8 · 2023: 11 · 2022: 7 · 2021: 6 · 2020: 6 · 2019: 8 · 2018: 1 · 2017: 1
FWCI
7.88
Type
journal article
Language
en
Open access
Licence
Locations
  • The European Journal of Health Economics (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • VU Research Portal (publishedVersion, other-oa)
  • University of Twente Research Information (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • UvA-DARE (University of Amsterdam) (submittedVersion)
  • University of Twente Research Information (submittedVersion)
Funders
  • KWF Kankerbestrijding (ALPE 2009- 4299)
  • CZ Fund
  • Achmea
  • Integraal Kankercentrum Nederland
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
Keywords
breast cancer, adjuvant chemotherapy, physical activity, cost-effectiveness, cost-utility analysis, fatigue, physical fitness, quality-adjusted life years, absenteeism, exercise adherence
MeSH terms
Adult, Breast Neoplasms, Cost-Benefit Analysis, Female, Humans, Middle Aged, Netherlands, Physical Fitness, Quality of Life, Exercise, Treatment Outcome, Chemotherapy, Adjuvant, Quality-Adjusted Life Years, Resistance Training, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy. https://app.cochat.ai/papers/10.1007/s10198-017-0936-0
The paper
van Waart, H., van Dongen, J. M., van Harten, W. H., Stuiver, M. M., Huijsmans, R., Hellendoorn-van Vreeswijk, J. A. J. H., Sonke, G. S., & Aaronson, N. K. (2018). Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy. The European Journal of Health Economics. https://doi.org/10.1007/s10198-017-0936-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.